McKesson HBOC, Inc. (10-K) Filing Summary
Business Context and Reporting Period
Company: McKesson HBOC, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2000
Business Overview: A leading North American health care services company organized into three segments: Health Care Supply Management (wholesale distribution of drugs and medical supplies), Health Care Information Technology (software and services), and e-Health (internet-based clinical applications). The company recently completed the acquisition of HBO & Company (HBOC) in a pooling of interests transaction and divested its non-health care Water Products business.
Key Financial Metrics
| Metric (in millions) | Fiscal 2000 | Fiscal 1999 | Fiscal 1998 |
|---|---|---|---|
| Revenues | $36,734.2 | $30,028.7 | $22,105.7 |
| Gross Profit | $2,322.4 | $2,399.2 | $2,158.6 |
| Gross Margin | 6.3% | 8.0% | 9.8% |
| Operating Profit | $580.1 | $310.0 | $579.8 |
| Net Income | $723.7 | $84.9 | $304.6 |
| Diluted EPS (Total) | $2.57 | $0.31 | $1.10 |
| Total Debt | $1,260.0 | $1,151.2 | $1,318.4 |
| Cash & Equivalents | $548.9 | $233.7 | $564.4 |
| Stockholders' Equity | $3,565.8 | $2,881.8 | $2,561.7 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 22.3% to $36.7 billion, driven primarily by the Health Care Supply Management segment (up 25% to $35.5 billion). The Health Care Information Technology segment revenues declined 22% to $1.2 billion due to industry slowdowns and accounting changes.
- Profitability: Net income surged to $723.7 million (up 752% from prior year), largely due to a one-time after-tax gain of $515.9 million from the sale of the Water Products business. Income from continuing operations was $184.6 million, a 205% increase over the prior year's $60.6 million.
- Margin Compression: Gross profit margin declined to 6.3% from 8.0% in the prior year, attributed to competitive pricing pressures and a shift in revenue mix toward lower-margin chain business in the supply segment.
- Divestiture: The company sold its Water Products business for approximately $1.1 billion in cash, classifying it as a discontinued operation.
- Acquisitions: Acquired Abaton.com for $95 million to bolster the e-Health segment and completed several smaller acquisitions in the supply and IT segments.
Guidance, Risks, and Unusual Items
Unusual Items & Charges:
- Restatement Costs: Incurred $18.9 million in pre-tax costs related to the investigation and restatement of prior financial results stemming from improper accounting practices at the acquired HBOC unit.
- Asset Impairments: Recorded $232.7 million in asset impairments and customer reserves in the Health Care Information Technology segment due to product streamlining and reorganization.
- Equity Gains: Recognized net gains of $269.1 million from the exchange and sale of equity investments (primarily Healtheon/WebMD), partially offset by unrealized losses on warrants.
Legal Proceedings & Risks:
- Securities Litigation: As of June 1, 2000, 79 lawsuits have been filed against the company and its officers regarding the financial restatement. The company cannot estimate the potential loss, but settlements or judgments could be material.
- Antitrust Actions: Defendant in numerous civil antitrust actions alleging price-fixing of pharmaceuticals. While federal claims against wholesalers were dismissed, state cases remain pending.
- Customer Concentration: Sales to the ten largest customers accounted for 52% of total revenues; the largest customer (Rite Aid) represented 15% of revenues.
- Environmental Liabilities: Estimated liability of approximately $19 million for remediation of former chemical business sites.
Outlook: Management anticipates a shift in the IT segment toward contract-based revenue recognition, which may dampen near-term revenue but provide more predictable streams. The company expects to continue facility closures and workforce reductions in the supply segment to improve efficiency.
Investor Verification Checklist
- Verify the status and potential financial impact of the 79 pending securities lawsuits related to the HBOC accounting restatement.
- Assess the sustainability of the Health Care Supply Management segment's revenue growth given the 15% concentration risk with Rite Aid Corporation.
- Review the Health Care Information Technology segment's ability to recover from a 22% revenue decline and the impact of the $232.7 million impairment charge on future earnings.
- Confirm the company's liquidity position following the $1.1 billion cash infusion from the Water Products sale and the subsequent reduction in short-term borrowings.
- Monitor the progress of the antitrust litigation (MDL 997) and the potential for indemnification from pharmaceutical manufacturer defendants.